Skip to main content

Advertisement

Table 2 Plating and Replating of lung and spleen for P-MAPA, MXF and MXF + P-MAPA antimycobacterial activities

From: Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer

Compounds Tissues
  Lung Spleen Spleen Replate
  Mean CFU log10 prot SEM n Mean CFU log10 prot SEM n Mean CFU log10prot SEM n
Untreated Ctrl 4.66 - 0.11 6/6 4.29 - 0.12 6/6 3.34 - 0.18 6/6
MXF 2.86a 1.80 0.13 6/6 2.80a 1.49 0.23 6/6 1.38a 1.96 0.29 5/6
P-MAPA 3.72a 0.94 0.10 6/6 3.74 0.55 0.12 6/6 2.31a 1.03 0.12 6/6
MXF + P-MAPA 2.91a 1.75 0.14 6/6 2.36a 1.93 0.32 6/6 0.69a 2.65 0.32 4/6
  1. n = Number of mice with CFU/total number of mice at sacrifice; MXF = Moxifloxacin; SEM = standard error of the mean; log10 prot = log10 CFU of protection; Letter a: significantly different from Untreated Ctrl group.